SCHEMBL4544341

SCHEMBL4544341

CCc1cc(C(=O)O)n(N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
RXRA P19793 2/20 0.37
RXRB P28702 2/20 0.37
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GPR35 Q9HC97 2/20 0.34
BCL2 P10415 1/20 0.34
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4544326 0.81 L3MBTL1 (0.40) ALDH1A1MAPTHSD17B10POLBTDP1
SCHEMBL14791059 0.80 CA12 (0.41) ALDH1A1MAPTMAPK1HSD17B10CA12
SCHEMBL27479237 0.74 TPMT (0.38) ALDH1A1RXRARXRBMAPK1HSD17B10
Lithium SCHEMBL31223142 0.73 CYP2C19 (0.46) ALDH1A1MAPTCA12CA9TDP1
SCHEMBL25815807 0.70 NPC1 (0.36) ALDH1A1MAPTMAPK1HSD17B10POLB
SCHEMBL21465765 0.69 MCL1 (0.37) ALDH1A1HCAR2AKR1C3AKR1C2POLB
SCHEMBL7052816 0.67 MAOA (0.36) ALDH1A1MAPTMAPK1HSD17B10GPR35
SCHEMBL7054295 0.65 TDP1 (0.41) ALDH1A1MAPTMAPK1HSD17B10GPR35
SCHEMBL13766359 0.64 MEN1 (0.48) ALDH1A1POLBL3MBTL1
SCHEMBL15604817 0.63 CA12 (0.42) ALDH1A1MAPK1HSD17B10CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150563-B2 Nitrogen-containing aromatic heterocyclyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-10-06 US disclosed
US-20140187592-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-07-03 US disclosed
US-8648103-B2 Nitrogen-containing aromatic heterocyclyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-02-11 US disclosed
US-20120108639-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187592-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND NPR1, NPR3, NPC1 ALDH1A1 1307/4885RXRA 891/4885RXRB 702/4885
US-20120108639-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND NPR1, NPR3, NPPA ALDH1A1 725/4885RXRA 732/4885RXRB 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.